Merck Signs Another Deal with 4D Pharma to Strengthen its Vaccine Portfolio
By Sharath Chandra Nakka
Pharma Deals Review: Vol 2019 Issue 10 (Table of Contents)
Published: 26 Oct-2019
DOI: 10.3833/pdr.v2019.i10.2466 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Merck Sharp & Dohme has entered into a research collaboration with UK-based 4D Pharma to discover and develop up to three vaccine candidates by using the latter’s proprietary platform - MicroRx...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS